CliniSys appoints senior vice president of global strategy

Published: 7-Feb-2022

New role to drive growth and integration of CliniSys products and services globally

CliniSys has announced that Mark Spencer has joined the company as senior vice president of global strategy.

A 25-year veteran in the life sciences and healthcare IT industry, Spencer will be charged with driving growth globally.

As the world looks to improve public health now and after the pandemic, he will work closely with the senior leadership team to realise CliniSys’ vision to support its customers both inside and beyond the walls of the clinical laboratory to embrace a new wave of community laboratories and digital diagnostics in healthcare, toxicology, agriculture, water and environmental testing.

The appointment follows CliniSys’ recent acquisition of HORIZON Lab Systems and merger with Sunquest Information Systems.

Spencer will play a critical role in integrating these business lines and product offerings to help organisations and governments better fight disease.

“CliniSys is at an exciting stage of growth after its recent M&A activity, priming it to deliver the integrated and holistic laboratory diagnostics that will drive the next wave of innovation in disease surveillance and tracking,” Spencer said.

“That is why I am looking forward to returning to the company and driving the strategies that will accelerate our growth in key regions globally."

A former manager at Sunquest, Spencer rejoins from Abbott Informatics, where he led the successful growth of its former laboratory information management system (STARLIMS).

“Mark brings with him a deep knowledge of healthcare and technology, and a wealth of experience leading an impressive list of successful business transformations in the sector,” said CliniSys chief executive, Michael Simpson.

You may also like